More information: Charlie A. Hamm et al, Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer, JAMA Oncology (2024). DOI: 10.1001/jamaoncol.2024.5497 ...

MRI should be considered an adjunct to, and not a replacement for, biopsies for men on active surveillance for prostate cancer. MRI does not consistently rule out the presence of Gleason grade ...

Clinical protocols to monitor efficacy of [177Lu]Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Association of PSMA PET results at biochemical recurrence (BCR) with metastasis free survival (MFS) by conventional imaging (CI) in patients with locally advanced or high-risk localized prostate ...

Serum prostate-specific antigen was3.4 ng/ml. Bone scintigraphy and baseline CT were reportedlynegative. Investigations: Physical examination, laboratory evaluation,endorectal MRI of the prostate ...